Long term survival for patients with advanced ovarian cancer can be achieved says an article published in the Journal of Surgical Oncology. The patients would need to undergo radical surgery and intraperitoneal chemotherapy.

So what does this mean? Intraperitoneal chemotherapy is when the patient gets chemotherapy delivered to the site of the cancer before being metabolized and broken down through our body's metabolic processes. Hyperthermic intraoperative chemotherapy (HIIC) is when the heating of tissues is added to aid in the uptake of chemotherapy into the tissues.


Researchers in Spain did a study that involved 19 patients who were recently diagnosed and 14 patients that had recurrent ovarian cancer. Patients underwent radical surgery and HIIC with the chemotherapy agent Taxol.

The researchers concluded that radical surgery followed by HIIC resulted in impressive survival among patients with advanced ovarian cancer.